Wednesday, June 10, 2026

Patent intelligence · CA

CA 2631716

CONJUGUES VECTEUR DE CIBLAGE-PHOSPHOLIPIDES

granted A61K 38/ 10 A IA61K 49/ 22 A IA61K/47544A61K/4914
Status granted
Years to expiry 1
Applicant portfolio 25
Patent details — CA 2631716
Jurisdiction
CA
Status
granted
Grant date
Jun 14, 2007
Expiration
Jun 9, 2027
Applicant
BRACCO INT BV [NL]
CPC classes
A61K 38/ 10 A I, A61K 49/ 22 A I, A61K/47544, A61K/4914
View on Google Patents ↗

Quick answer

CA 2631716 (CONJUGUES VECTEUR DE CIBLAGE-PHOSPHOLIPIDES) is held by BRACCO INT BV [NL]. Status: granted. Granted Jun 14, 2007. Expires Jun 9, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
BRACCO INT BV [NL]
Grant date
Expiration
Claims
CPC classes
A61K 38/ 10 A I, A61K 49/ 22 A I, A61K/47544, A61K/4914, A61K/49223

More from BRACCO INT BV [NL]

Related pharmaceutical patents in our USPTO index.

  1. IL 172160

    Method for non-invasive quantification of perfusion in a tissue

    BRACCO SUISSE SA [CH] · Expires Apr 25, 2035

    granted
  2. EP 2117603

    TARGETING UND THERAPEUTISCHE VERBINDUNGEN UND GASGEFÜLLTE MIKROVESIKEL MIT DIESEN VERBINDUNGEN

    BRACCO INT BV [NL] · Expires Nov 13, 2029

    granted
  3. WO 2009076388

    CONJUGUÉS VECTEUR DE CIBLAGE - PHOSPHOLIPIDE

    BRACCO INT BV [NL] · Expires Jun 13, 2029

    granted
  4. CA 2670932

    DETECTION DU DETACHEMENT D'UN AGENT DE CONTRASTE IMMOBILISE DANS DES APPLICATIONS D'IMAGERIE MEDICALE

    BRACCO INT BV [NL] · Expires Jun 21, 2028

    granted
  5. US 2008107607

    TARGETING VECTOR-PHOSPHOLIPID CONJUGATES

    BRACCO INT BV [NL] · Expires May 3, 2028

    granted
  6. US 2008063603

    ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM

    BRACCO INT BV [NL] · Expires Mar 8, 2028

    granted
  7. US 2007128117

    Ultrasound contrast agents and process for the preparation thereof

    BRACCO INT BV [NL] · Expires Jun 2, 2027

    granted

Frequently asked questions

What is US patent 2631716?

CA 2631716 (CONJUGUES VECTEUR DE CIBLAGE-PHOSPHOLIPIDES) is held by BRACCO INT BV [NL]. Status: granted. Granted Jun 14, 2007. Expires Jun 9, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.

Who owns CA 2631716?

BRACCO INT BV [NL] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does CA 2631716 expire?

Our index shows an expiration date of Jun 9, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.